Drastic Synergy of Lovastatin and


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
24 Oct 2023
Historique:
received: 28 09 2023
revised: 20 10 2023
accepted: 21 10 2023
medline: 15 11 2023
pubmed: 14 11 2023
entrez: 14 11 2023
Statut: epublish

Résumé

Prostate cancer (PC) is the second most frequently diagnosed cancer and the fifth leading cause of cancer-related death in males worldwide. Early-stage PC patients can benefit from surgical, radiation, and hormonal therapies; however, once the tumor transitions to an androgen-refractory state, the efficacy of treatments diminishes considerably. Recently, the exploration of natural products, particularly dietary phytochemicals, has intensified in response to addressing this prevailing medical challenge. In this study, we uncovered a synergistic effect from combinatorial treatment with lovastatin (an active component in red yeast rice) and

Identifiants

pubmed: 37960146
pii: nu15214493
doi: 10.3390/nu15214493
pmc: PMC10647293
pii:
doi:

Substances chimiques

Androgens 0
Lovastatin 9LHU78OQFD
Biological Products 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Health Research Institutes, Miaoli, Taiwan
ID : CA-111-PP-16
Organisme : Health and welfare surcharge of tobacco products, Taiwan
ID : MOHW103-TD-B-111-01 and MOHW104-TDU-B-212-124-001
Organisme : Research grant from Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan
ID : 110-wf-eva-11

Références

Chin J Physiol. 2008 Apr 30;51(2):78-84
pubmed: 18666710
Appl Microbiol Biotechnol. 2010 Jan;85(4):869-83
pubmed: 19820926
Lancet. 2007 Dec 1;370(9602):1829-39
pubmed: 18061058
Prostate. 2016 Apr;76(5):469-78
pubmed: 26689439
Clin Cancer Res. 2001 Jan;7(1):158-67
pubmed: 11205904
Int J Cancer. 2014 Jan 15;134(2):268-79
pubmed: 23824972
Invest Urol. 1979 Jul;17(1):16-23
pubmed: 447482
Curr Cancer Drug Targets. 2005 Dec;5(8):579-94
pubmed: 16375664
J Clin Invest. 2018 Jan 2;128(1):341-358
pubmed: 29202480
Cancer Res. 2022 Jan 15;82(2):221-234
pubmed: 34625422
J Food Biochem. 2019 Aug;43(8):e12936
pubmed: 31368557
Cancer. 2004 Feb 15;100(4):751-7
pubmed: 14770431
Eur J Cancer. 2005 Mar;41(4):523-30
pubmed: 15737556
Nat Med. 2011 Feb;17(2):211-5
pubmed: 21240262
Discov Med. 2015 Dec;20(112):413-27
pubmed: 26760985
J Biol Chem. 2009 Feb 6;284(6):3823-32
pubmed: 19075016
Biochim Biophys Acta Gen Subj. 2021 Sep;1865(9):129952
pubmed: 34147543
EMBO Mol Med. 2012 Sep;4(9):896-909
pubmed: 22887866
Oncogene. 2013 Feb 7;32(6):689-98
pubmed: 22410775
JAMA. 2013 Dec 11;310(22):2451-2
pubmed: 24276813
Nutr Cancer. 2007;57(1):111-21
pubmed: 17516868
Front Public Health. 2022 Feb 16;10:811044
pubmed: 35252092
Int J Cancer. 1978 Mar 15;21(3):274-81
pubmed: 631930
Cancer Lett. 2021 May 1;505:24-36
pubmed: 33617947
Cell Death Differ. 2012 Jul;19(7):1152-61
pubmed: 22322860
Cancer Res. 2008 Feb 15;68(4):1128-35
pubmed: 18281488
Neoplasia. 2010 Feb;12(2):116-27
pubmed: 20126470
Molecules. 2022 Sep 05;27(17):
pubmed: 36080493
Br J Clin Pharmacol. 1996 Sep;42(3):333-7
pubmed: 8877024
Cancers (Basel). 2018 Sep 21;10(10):
pubmed: 30248934
Cancers (Basel). 2022 Nov 05;14(21):
pubmed: 36358865
Commun Biol. 2022 Jun 25;5(1):625
pubmed: 35752711
N Engl J Med. 2019 Sep 5;381(10):e19
pubmed: 31483981
P T. 2009 Jun;34(6):313-27
pubmed: 19572049
J Urol. 2011 Apr;185(4):1268-73
pubmed: 21334020
Int J Radiat Oncol Biol Phys. 2015 Oct 1;93(2):316-25
pubmed: 26277021
Mol Cancer. 2019 Nov 4;18(1):153
pubmed: 31684958
iScience. 2021 Oct 14;24(11):103270
pubmed: 34761189
Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):E6457-E6466
pubmed: 27694579
Cancers (Basel). 2022 Sep 19;14(18):
pubmed: 36139695
Cancer Res. 2017 Feb 15;77(4):982-995
pubmed: 27923835
Prostate Cancer Prostatic Dis. 2022 Apr;25(4):650-656
pubmed: 35768578
Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):88-94
pubmed: 18199714
Carcinogenesis. 2001 Oct;22(10):1727-31
pubmed: 11577016
Front Cell Dev Biol. 2023 Jul 24;11:1236968
pubmed: 37554307
J Clin Oncol. 2004 Jun 15;22(12):2388-94
pubmed: 15197200
Cancer Discov. 2021 Sep;11(9):2334-2353
pubmed: 33879449
Cancer Gene Ther. 2022 Nov;29(11):1550-1557
pubmed: 35440696
Prostate Cancer Prostatic Dis. 2022 Apr;25(4):641-649
pubmed: 35732821
Biochem Biophys Res Commun. 2008 Aug 29;373(3):423-8
pubmed: 18573234
Asian J Urol. 2019 Jan;6(1):26-41
pubmed: 30775246
Clin Cancer Res. 1996 Mar;2(3):483-91
pubmed: 9816194

Auteurs

Chih-Jung Yao (CJ)

Department of Medical Education and Research, Wan Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan.
Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.

Chia-Lun Chang (CL)

Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.
Division of Hematology and Medical Oncology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan.
Cancer Center, Wan Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan.

Ming-Hung Hu (MH)

Division of Hematology and Medical Oncology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan.
Cancer Center, Wan Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan.

Chien-Huang Liao (CH)

Cancer Center, Wan Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan.

Gi-Ming Lai (GM)

Division of Hematology and Medical Oncology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan.
Cancer Center, Wan Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan.

Tzeon-Jye Chiou (TJ)

Division of Hematology and Medical Oncology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan.
Cancer Center, Wan Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan.

Hsien-Ling Ho (HL)

Cancer Center, Wan Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan.

Hui-Ching Kuo (HC)

Cancer Center, Wan Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan.

Ya-Yu Yang (YY)

National Institute of Cancer Research, National Health Research Institutes, Miaoli 35053, Taiwan.

Jacqueline Whang-Peng (J)

Division of Hematology and Medical Oncology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan.
Cancer Center, Wan Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan.

Shuang-En Chuang (SE)

National Institute of Cancer Research, National Health Research Institutes, Miaoli 35053, Taiwan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH